Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (437)
Cancellation by sponsor (155)
Prescription medicine registration (29)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (40)
2024 (47)
2023 (36)
2022 (54)
2021 (41)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

631 result(s) found, displaying 171 to 180

ATORVASTATIN RAN atorvastatin (as calcium trihydrate) 20 mg tablets blister pack (354109)

19 June 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATORVASTATIN RAN atorvastatin (as calcium trihydrate) 20 mg tablets blister pack.
ATORVASTATIN RAN atorvastatin (as calcium trihydrate) 40 mg tablets bottle (354104)

19 June 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATORVASTATIN RAN atorvastatin (as calcium trihydrate) 40 mg tablets bottle.
TROVAS atorvastatin (as calcium trihydrate) 10 mg tablets bottle (354106)

19 June 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TROVAS atorvastatin (as calcium trihydrate) 10 mg tablets bottle.
LENALIDOMIDE SUN/LENALIDOMIDE RBX/LENALIDOMIDE RAN (Sun Pharma ANZ Pty Ltd)

20 December 2022

Prescription medicine registration

Active ingredients: Lenalidomide.
MESALAZINE SUN/ MESALZ (Sun Pharma ANZ Pty Ltd)

14 December 2022

Prescription medicine registration

Active ingredients: Mesalazine.
AMPHOTERICIN LIPOSOMAL RAN (Sun Pharma ANZ Pty Ltd)

28 November 2022

Prescription medicine registration

Active ingredients: amphotericin B (amphotericin).
TETRABENAZINE RAN/TETRABENAZINE SUN/TETRABENAZINE RBX (Sun Pharma ANZ Pty Ltd)

22 November 2022

Prescription medicine registration

Active ingredients: Tetrabenazine.
ABACAVIR/LAMIVUDINE 600/300 SUN abacavir 600 mg / lamivudine 300 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

12 September 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
ABACAVIR/LAMIVUDINE 600/300 SUN abacavir 600 mg / lamivudine 300 mg tablets bottle Cancelled under Section 30(1)(c) of the Act

12 September 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
BUFOMIX EASYHALER (Sun Pharma ANZ Pty Ltd)

6 September 2022

Prescription medicine registration

Active ingredients: Budesonide, formoterol (eformoterol) fumarate dihydrate.

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.